Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Is quality of life different between diabetic and non-diabetic people? The importance of cardiovascular risks
- L. Peña-Longobardo, B. Rodríguez-Sánchez, M. Mata-Cases, L. Rodríguez-Mañas, M. Capel, J. Oliva-Moreno
- PloS one
- 14 December 2017
Background To analyse and compare the impact of cardiovascular risk factors and disease on health-related quality of life (HRQoL) in people with and without diabetes living in the community. Methods… Expand
Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment
- M. Capel, M. Mareque, C. Álvarez, L. Lindner, I. Oyagüez
- Clinical Drug Investigation
- 13 April 2018
Background and ObjectiveChronic obstructive pulmonary disease (COPD), a progressive lung disorder associated with decline of respiratory function, affects 10.2% of Spanish adults (40–80 years of… Expand
A Comparison of Budesonide/Formoterol Maintenance and Reliever Therapy Versus Conventional Best Practice in Asthma Management in Spain
- S. Quirce, C. Barcina, +4 authors M. Capel
- The Journal of asthma : official journal of the…
- 26 September 2011
Objective. To study the effectiveness and safety in a real-life setting of budesonide/formoterol (Symbicort) Maintenance And Reliever Therapy® (Symbicort SMART®), a simplified management approach… Expand
Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain
- V. Barrios, J. Lobos, A. Serrano, M. Brosa, M. Capel, C. Alvarez Sanz
- Journal of medical economics
- 6 September 2012
Abstract Objective: The objective of this study was to carry out a long-term cost-effectiveness analysis of rosuvastatin compared with generic atorvastatin in the treatment of patients at high… Expand
Efficiency of naproxen/esomeprazole in association for osteoarthrosis treatment in Spain.
OBJECTIVE To assess, from the perspective of the National Healthcare System, the efficiency of a fixed-dose combination of naproxen and esomeprazole (naproxen/esomeprazole) in the treatment of… Expand
Efficiency of Naproxen/Esomeprazole in Association for Osteoarthrosis Treatment in Spain
Abstract Objective To assess, from the perspective of the National Healthcare System, the efficiency of a fixed-dose combination of naproxen and esomeprazole (naproxen/esomeprazole) in the treatment… Expand
The Cost-Effectiveness of Dapagliflozin In Combination With Insulin for the Treatment of Type 2 Diabetes Mellitus (T2dm) In Spain.
Economics Analysis of Dapagliflozin Compare to Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus in Spain: Cost of Achieving Composite Endpoints.
Cost-Effectiveness Analysis of Dapaglifozin Versus Other T2DM Treatments in the Spanish Context